English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/152762
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease

AuthorsBueno, Clara; Roldan, Mar; Anguita, Eduardo; Romero-Moya, Damia; Martín-Antonio, Beatriz; Rosu-Myles, Michael; del Cañizo, Consuelo; Campos, Francisco ; García, Regina; Gómez-Casares, M. Teresa; Fuster, José Luis; Jurado, Manuel; Delgado, M.; Menéndez, Pablo
KeywordsSTROMAL CELLS
HEMATOPOIETIC-CELLS
ENDOTHELIAL-CELLS
ENGRAFTMENT
TRANSPLANTATION
THAILAND
COTRANSPLANTATION
ABNORMALITIES
EPIDEMIOLOGY
MAINTENANCE
Issue DateJul-2014
PublisherFerrata Storti Foundation
CitationHaematologica - the Hematology Journal
AbstractAplastic anemia is a life-threatening bone marrow failure disorder characterized by peripheral pancytopenia and marrow hypoplasia. The majority of cases of aplastic anemia remain idiopathic, although hematopoietic stem cell deficiency and impaired immune responses are hallmarks underlying the bone marrow failure in this condition. Mesenchymal stem/stromal cells constitute an essential component of the bone marrow hematopoietic microenvironment because of their immunomodulatory properties and their ability to support hematopoiesis, and they have been involved in the pathogenesis of several hematologic malignancies. We investigated whether bone marrow mesenchymal stem cells contribute, directly or indirectly, to the pathogenesis of aplastic anemia. We found that mesenchymal stem cell cultures can be established from the bone marrow of aplastic anemia patients and display the same phenotype and differentiation potential as their counterparts from normal bone marrow. Mesenchymal stem cells from aplastic anemia patients support the in vitro homeostasis and the in vivo repopulating function of CD34+ cells, and maintain their immunosuppressive and anti-inflammatory properties. These data demonstrate that bone marrow mesenchymal stem cells from patients with aplastic anemia do not have impaired functional and immunological properties, suggesting that they do not contribute to the pathogenesis of the disease.
DescriptionObtained from the Haematologica Journal website http://www.haematologica.org
Publisher version (URL)http://www.haematologica.org/content/99/7/1168.long
URIhttp://hdl.handle.net/10261/152762
DOI10.3324/haematol.2014.103580
ISSN0390-6078
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
Bone_marrow.pdf18,31 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.